BavachromeneCAS# 41743-38-8 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 41743-38-8 | SDF | Download SDF |
PubChem ID | 5321800 | Appearance | Yellow powder |
Formula | C20H18O4 | M.Wt | 322.4 |
Type of Compound | Chalcones | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (E)-1-(7-hydroxy-2,2-dimethylchromen-6-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one | ||
SMILES | CC1(C=CC2=CC(=C(C=C2O1)O)C(=O)C=CC3=CC=C(C=C3)O)C | ||
Standard InChIKey | LYPURLGLYLCBSU-VMPITWQZSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Bavachromene exhibits a significant inhibitory effect on baculovirus-expressed BACE-1 in vitro. |
Targets | BACE |
Bavachromene Dilution Calculator
Bavachromene Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.1017 mL | 15.5087 mL | 31.0174 mL | 62.0347 mL | 77.5434 mL |
5 mM | 0.6203 mL | 3.1017 mL | 6.2035 mL | 12.4069 mL | 15.5087 mL |
10 mM | 0.3102 mL | 1.5509 mL | 3.1017 mL | 6.2035 mL | 7.7543 mL |
50 mM | 0.062 mL | 0.3102 mL | 0.6203 mL | 1.2407 mL | 1.5509 mL |
100 mM | 0.031 mL | 0.1551 mL | 0.3102 mL | 0.6203 mL | 0.7754 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Croalbidine
Catalog No.:BCN2068
CAS No.:41714-30-1
- Indicine N-oxide
Catalog No.:BCN1996
CAS No.:41708-76-3
- Epimagnolin A
Catalog No.:BCN7831
CAS No.:41689-51-4
- Epiaschantin
Catalog No.:BCN7206
CAS No.:41689-50-3
- 8-Acetoxypentadeca-1,9Z-diene-4,6-diyn-3-ol
Catalog No.:BCN1444
CAS No.:41682-30-8
- Arctigenin 4'-O-beta-gentiobioside
Catalog No.:BCN2847
CAS No.:41682-24-0
- 8-Methyleugenitol
Catalog No.:BCN6459
CAS No.:41682-21-7
- 4',7-Dihydroxyflavanone
Catalog No.:BCC8333
CAS No.:41680-09-5
- 2H-1-Benzopyran-7-yloxy
Catalog No.:BCN3580
CAS No.:41680-08-4
- Catharanthine hemitartrate
Catalog No.:BCN8463
CAS No.:4168-17-6
- 7-O-Methyl morroniside
Catalog No.:BCN3882
CAS No.:41679-97-4
- Koaburaside
Catalog No.:BCN5475
CAS No.:41653-73-0
- Procyanidin A2
Catalog No.:BCN6805
CAS No.:41743-41-3
- Luteone
Catalog No.:BCN5476
CAS No.:41743-56-0
- Sugeroside
Catalog No.:BCN6961
CAS No.:41743-57-1
- Pyrochamissanthin
Catalog No.:BCN3612
CAS No.:41743-60-6
- Irisflorentin
Catalog No.:BCN1278
CAS No.:41743-73-1
- (-)-Sativan
Catalog No.:BCN7752
CAS No.:41743-86-6
- Acuminatin
Catalog No.:BCN5477
CAS No.:41744-39-2
- Ginsenoside Rb1
Catalog No.:BCN1063
CAS No.:41753-43-9
- Ophiopogonin D
Catalog No.:BCN5004
CAS No.:41753-55-3
- Dihydrophaseic acid
Catalog No.:BCN5478
CAS No.:41756-77-8
- Evonimine
Catalog No.:BCN3082
CAS No.:41758-69-4
- ar-Curcumene
Catalog No.:BCN7534
CAS No.:4176-06-1
In vitro BACE-1 inhibitory phenolic components from the seeds of Psoralea corylifolia.[Pubmed:18666047]
Planta Med. 2008 Sep;74(11):1405-8.
A new isoflavone, neocorylin ( 1) was isolated from the seeds extract of Psoralea corylifolia L. (Fabaceae), together with eight known constituents ( 2 - 9), i. e., bakuchiol ( 2), psoralen ( 3), Bavachromene ( 4), isoBavachromene ( 5), bavachalcone ( 6), isobavachalcone ( 7), 7,8-dihydro-8-(4-hydrophenyl)-2,2-dimethyl-2 H,6 H-[1,2- B:5,4- B']dipyran-6-one ( 8), and bavachinin ( 9). The structure of the new isoflavone 1 was elucidated as 7-hydroxy-3-[2-methyl-2-(4-methylpenten-3-yl)-2 H-chromen-6-yl]-4 H-chromen-4-one by spectroscopic analyses. Neocorylin ( 1) as well as related compounds 2, 4 - 6, 8 and 9 exhibited a significant inhibitory effect on baculovirus-expressed BACE-1 in vitro.